Fighting rare cancers: lessons from fibrolamellar hepatocellular carcinoma
When a scientist’s daughter is diagnosed with a rare cancer, he works collaboratively to find new ideas and harnesses patient power.
Read more
Kelli Duprey, vice chair, OurBrainBank
I attended the 27th annual meeting and education day held by SNO…
Crisis What Crisis? podcast
Our UK board members Andy Coulson and Richard Clemmow recently recorded a podcast to highlight the work of OurBrainBank.
All in My Head
After Jessica Morris was diagnosed with glioblastoma in 2016 until a few months before she died…
Kyle Humphries – GBM survivor
Kyle Humphries, who lives in New York City, is a GBM survivor who has been through surgery, radiation, chemotherapy, a clinical trial and integrative medicines.
OurBrainBank Wins Forbes EQ BrandVoice 2024: First Article Features Jessica Morris’s book
OBB founder Jessica Morris’s book is excerpted by Forbes.
UK ranks 22nd out of 29 comparable countries for survival of Brain Cancer
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
Experimental GBM treatment — DC Vax — is hoped to be moving forward in the UK
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
SUBSCRIBE TO OUR NEWSLETTER
GET INVOLVED
